Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Prince

Showing results (111-120 of 151) with videos related to

Pageof 16
Sort By:
Bone Marrow Transplantation|December 2, 2000
Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I studyH M Prince, D Rischin, G C Toner, et al.
Blood Cancer Journal|August 9, 2014
Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expressionY Oki, D Buglio, J Zhang, et al.
Bone Marrow Transplantation|April 1, 1999
Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancerH M Prince, J Gardyn, M J Millward, et al.
Cytotherapy|May 15, 2002
Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapyH M Prince, J Bashford, D Wall, et al.
Rheumatology (Oxford, England)|June 17, 2015
Long-term quality of life and functional outcome of patients with juvenile idiopathic arthritis in the biologic era: a longitudinal follow-up study in the Dutch Arthritis and Biologicals in Children RegisterJanneke Anink, Femke H M Prince, Maryanne Dijkstra, et al.
Annals of the Rheumatic Diseases|April 17, 2008
Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national registerF H M Prince, M Twilt, R ten Cate, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2018
Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicityA J Davenport, R S Cross, K A Watson, et al.
The Journal of Rheumatology|April 5, 2011
Development of inflammatory bowel disease in patients with juvenile idiopathic arthritis treated with etanerceptTrudy D van Dijken, Sebastiaan J Vastert, Valeria M Gerloni, et al.
Internal Medicine Journal|March 5, 2015
Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: position statement of the myeloma foundation of Australia Medical and Scientific Advisory GroupH Quach, D Joshua, J Ho, et al.
British Journal of Cancer|June 29, 2013
Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapyC Y Cheah, M S Hofman, M Dickinson, et al.
Pageof 16

Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
Bone Marrow Transplantation|December 2, 2000
Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I studyH M Prince, D Rischin, G C Toner, et al.
Blood Cancer Journal|August 9, 2014
Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expressionY Oki, D Buglio, J Zhang, et al.
Bone Marrow Transplantation|April 1, 1999
Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancerH M Prince, J Gardyn, M J Millward, et al.
Cytotherapy|May 15, 2002
Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapyH M Prince, J Bashford, D Wall, et al.
Rheumatology (Oxford, England)|June 17, 2015
Long-term quality of life and functional outcome of patients with juvenile idiopathic arthritis in the biologic era: a longitudinal follow-up study in the Dutch Arthritis and Biologicals in Children RegisterJanneke Anink, Femke H M Prince, Maryanne Dijkstra, et al.
Annals of the Rheumatic Diseases|April 17, 2008
Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national registerF H M Prince, M Twilt, R ten Cate, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2018
Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicityA J Davenport, R S Cross, K A Watson, et al.
The Journal of Rheumatology|April 5, 2011
Development of inflammatory bowel disease in patients with juvenile idiopathic arthritis treated with etanerceptTrudy D van Dijken, Sebastiaan J Vastert, Valeria M Gerloni, et al.
Internal Medicine Journal|March 5, 2015
Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: position statement of the myeloma foundation of Australia Medical and Scientific Advisory GroupH Quach, D Joshua, J Ho, et al.
British Journal of Cancer|June 29, 2013
Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapyC Y Cheah, M S Hofman, M Dickinson, et al.
Pageof 16